Redenlab is supporting a new speech focussed consortium for ataxia. SpeechATAXIA is a multi-language, multi-national, multi-ataxia study measuring communication change. Participants are recruited from investigator sites in Australia, New Zealand, Europe, North and South America.

The consortia goals include:
– Precisely describe longitudinal changes occurring in speech as disease progresses,
– Identify predictors of progression and discover if critical milestones exist in the disease course,
– Explore how communication decline shapes quality of life and disease management,
– Strengthen genotype-phenotype associations to create disease specific profiles.

The program of research is supported by the Ataxia Global Initiative.